Post job

Goldfinch Bio's revenue is $1.4 million.

What is Goldfinch Bio's revenue?

Goldfinch Bio's annual revenue is $1.4M. Zippia's data science team found the following key financial metrics about Goldfinch Bio after extensive research and analysis.
  • Goldfinch Bio has 61 employees, and the revenue per employee ratio is $22,951.
  • Goldfinch Bio peak revenue was $1.4M in 2024.

On this page

Peak revenue
$1.4M (2025)
Company peak revenue
Revenue / employee
$22,951
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Peak revenue
$1.4M (2025)
Company peak revenue
Revenue / employee
$22,951
Company revenue / employee

Goldfinch Bio financing

Goldfinch Bio received early financing of $55.0M on 2016-12-14.

SeriesRound sizeDate
Series A$55M12/2016
Corporate Round$55M05/2019
Series B$100M06/2020

Goldfinch Bio investors

InvestorsSecurity type
Third Rock VenturesSeries A
Gilead Sciences, Inc.Corporate Round
Eventide Asset ManagementSeries B
Schroder AdveqSeries B
Ally Bridge GroupSeries B
Wellington ManagementSeries B
Regent CapitalSeries B
Gilead Sciences, Inc.Series B
Casdin CapitalSeries B
Irving InvestorsSeries B
BlackRock, Inc.Series B

Goldfinch Bio competitors

Goldfinch Bio's top competitor, XORTX Therapeutics, earned an annual revenue of $6.2B.

Goldfinch Bio's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Tarsa Therapeutics-$1.6M10-
XORTX Therapeutics-$6.2B2-
Tmunity-$5.0M126-
AsclepiX Therapeutics-$1.1M17-
Onconova Therapeutics-$226,00012-
Sapience Therapeutics-$510,00015-

Goldfinch Bio revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Goldfinch Bio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Goldfinch Bio. The employee data is based on information from people who have self-reported their past or current employments at Goldfinch Bio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Goldfinch Bio. The data presented on this page does not represent the view of Goldfinch Bio and its employees or that of Zippia.

Goldfinch Bio may also be known as or be related to Goldfinch Bio, Goldfinch Bio Inc, Goldfinch Biopharma and Goldfinch Biopharma Inc.